3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Neoplasms
7
Breast Neoplasms
7
Head and Neck Neoplasms
5
Glioblastoma
4
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Melanoma
3
Hematologic Neoplasms
3
Glioma
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Lymphedema
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hematopoietic and Lymphatic System Neoplasm
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Astrocytoma
2
Xeroderma Pigmentosum
1
Triple Negative Breast Neoplasms
1
Trichothiodystrophy Syndromes
1
Tongue Neoplasms
1
Spinal Cord Neoplasms
1
Smoking Cessation
1
Smoking
1
Signs and Symptoms, Digestive
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Rectal Neoplasms
1
Interventions
Gemcitabine
7
Doxorubicin
4
Cyclophosphamide
4
pembrolizumab
3
Magnetic Resonance Spectroscopy
3
Docetaxel
3
Cisplatin
3
regorafenib
2
Vincristine
2
Tranexamic Acid
2
Sunitinib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Radiosurgery
2
Radiation
2
Proton Therapy
2
Nivolumab
2
Methotrexate
2
Methods
2
Interviews as Topic
2
Indocyanine Green
2
Everolimus
2
Curettage
2
Ascorbic Acid
2
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
2
tocilizumab
1
samarium Sm-153 lexidronam
1
poly ICLC
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Bone Neoplasms
×
Restraint, Physical
×
Clear all
NCT05051059
2026-03-16
QOLSarcoma
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
60 enrolled